Monitoring of antibodies against SARS-CoV-2 over 2 years and characterization of immune responses following Omicron infection in a South Indian community cohort.

Publication date: Jul 09, 2025

Multiple severe acute respiratory syndrome (SARS-CoV-2) exposures either due to infection or vaccination result in differential immune responses. Limited data exist on community-level SARS-CoV-2 variant exposures in India. We assessed antibody levels in 211 unvaccinated and 349 vaccinated individuals with and without prior exposure, followed for ~ 2 years (May 2021-October 2023) with baseline blood, weekly saliva for RT-PCR, and blood draws at ~ 6, 12, and 24 months. Humoral and cellular immune responses following primary (N = 8) and secondary (N = 11) Omicron infections in unvaccinated, previously exposed (N = 25), and unexposed vaccinated (N = 14) individuals were evaluated using Meso Scale Discovery and flow cytometry assays at Day 0, 30, and 90. Previously exposed individuals had higher anti-spike IgG levels at baseline (median 57,732 vs. 11,359, p 

Open Access PDF

Concepts Keywords
Infections Adolescent
Months Adult
Pcr Antibodies, Viral
Vaccinated Antibodies, Viral
Antibody kinetics
Antigen imprinting
CD8-Positive T-Lymphocytes
Cohort Studies
COVID-19
COVID-19 vaccination
COVID-19 Vaccines
COVID-19 Vaccines
Female
Humans
Immunity, Cellular
Immunity, Humoral
Immunoglobulin G
Immunoglobulin G
India
Male
Middle Aged
Omicron variant
SARS-CoV-2
Spike Glycoprotein, Coronavirus
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2
Vaccination
Young Adult

Semantics

Type Source Name
disease MESH infection
disease MESH severe acute respiratory syndrome
disease IDO blood
disease MESH COVID-19

Original Article

(Visited 4 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *